The arrival of COVID-19 in Japan in early 2020 prompted a concerted research effort at RIKEN. A strong research capacity in immunology, molecular biology.
Responding to the challenge of COVID-19 riken.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from riken.jp Daily Mail and Mail on Sunday newspapers.
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application Novo Integrated Sciences, Inc. (OTCQB:NVOS) (OTCQB:NVOSD), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S. (the Company”), announced today it has effected a 1-for-10 reverse split of its common stock effective prior to the opening of the market today, Monday, February 1, 2021. Beginning today, the Companys common stock will trade on a post-split basis under the symbol NVOSD. After 20 business days, the common stock will return to trading under the symbol NVOS. As a result of the reverse stock split, the CUSIP number for the Companys common stock has changed. The new CUSIP number for the Companys common stock is 67011T 201.